1-5 of 5
Jeffrey V. Ravetch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

David A. Knorr, Lucas Blanchard, Rom S. Leidner, Shawn M. Jensen, Ryan Meng, Andrew Jones, Carmen Ballesteros-Merino, Richard B. Bell, Maria Baez, Alessandra Marino, David Sprott, Carlo B. Bifulco, Brian Piening, Rony Dahan, Juan C. Osorio, Bernard A. Fox, Jeffrey V. Ravetch
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (3): 322–333.
https://doi.org/10.1158/2326-6066.CIR-23-0389
Published: 04 March 2024
View article titled, FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
Open the PDF for FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

Abstract B28: Improved therapeutic activity of agonistic, human anti-CD40 monoclonal Abs by selective FcγR-engagement

Rony Dahan, Bryan C. Barnhart, Alan J. Korman, Jeffrey V. Ravetch
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (3_Supplement): B28.
https://doi.org/10.1158/2326-6074.TUMIMM16-B28
Published: 28 February 2017
View article titled, Abstract B28: Improved therapeutic activity of agonistic, human anti-CD40 monoclonal Abs by selective FcγR-engagement
Journal Articles

Abstract B014: Improved therapeutic activity of agonistic, human anti-CD40 monoclonal Abs by selective Fc receptor-engagement

Rony Dahan, Jeffrey V. Ravetch
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): B014.
https://doi.org/10.1158/2326-6066.IMM2016-B014
Published: 31 October 2016
View article titled, Abstract B014: Improved therapeutic activity of agonistic, human anti-CD40 monoclonal Abs by selective Fc receptor-engagement
Journal Articles

Abstract B179: Enhancing intratumoural Treg depletion through antibody engineering and analysis of the checkpoint landscape of mouse and human cancers

Frederick Arce Vargas, Andrew J. Furness, Marta H. Lesko, Martin Pule, Jeffrey V. Ravetch, Karl S. Peggs, Sergio A. Quezada
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): B179.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B179
Published: 03 January 2016
View article titled, Abstract B179: Enhancing intratumoural Treg depletion through antibody engineering and analysis of the checkpoint landscape of mouse and human cancers
Journal Articles

Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions

David J. DiLillo, Jeffrey V. Ravetch
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (7): 704–713.
https://doi.org/10.1158/2326-6066.CIR-15-0120
Published: 01 July 2015
View article titled, Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions
Open the PDF for Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions in another window